Holen Sie sich die Stockscreener-App
6.11
2.24%
-0.14
Handel nachbörslich:
6.05
-0.06
-0.98%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BHC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$6.25
Offen:
$6.22
24-Stunden-Volumen:
1.32M
Relative Volume:
0.60
Marktkapitalisierung:
$2.25B
Einnahmen:
$9.47B
Nettoeinkommen (Verlust:
$-178.00M
KGV:
-12.73
EPS:
-0.48
Netto-Cashflow:
$1.01B
1W Leistung:
-10.28%
1M Leistung:
-17.88%
6M Leistung:
-25.12%
1J Leistung:
-40.10%
1-Tages-Spanne:
$6.055
$6.2366
1-Wochen-Bereich:
$6.055
$6.86
52-Wochen-Spanne:
$3.96
$11.46
Bausch Health Companies Inc Stock (BHC) Company Profile
Firmenname
Bausch Health Companies Inc
Sektor
Telefon
514-744-6792
Adresse
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Vergleichen Sie BHC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
6.11 | 2.25B | 9.47B | -178.00M | 1.01B | -0.48 |
|
ZTS
Zoetis Inc
|
163.50 | 72.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.98 | 47.08B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.16 | 45.99B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.29 | 17.52B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
312.26 | 13.78B | 2.76B | 1.11B | 898.10M | 22.77 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-02 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | Herabstufung | Truist | Buy → Hold |
| 2022-07-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-06-13 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-02-17 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-08-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-17 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-24 | Eingeleitet | Citigroup | Buy |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-12-02 | Eingeleitet | Goldman | Neutral |
| 2019-10-25 | Eingeleitet | Cowen | Outperform |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
| 2019-08-15 | Hochstufung | TD Securities | Hold → Buy |
| 2019-07-19 | Eingeleitet | Wolfe Research | Outperform |
| 2019-06-11 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-03-20 | Eingeleitet | SunTrust | Buy |
| 2019-01-02 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | Hochstufung | Piper Jaffray | Underweight → Neutral |
Alle ansehen
Bausch Health Companies Inc Aktie (BHC) Neueste Nachrichten
Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month - Corsicana Daily Sun
Oral Mucositis Market reached US$ 1.62 billion in 2023 and - openPR.com
Bausch + Lomb Brief: Adds Cause "Could Not Immediately Be Explained" - MarketScreener
Bausch + Lomb Brief: Announcing a Voluntary Recall of Intraocular Lenses (IOLs) On Its enVista Platform - MarketScreener
Bausch Health to Announce First Quarter Results on April 30 - guardonline.com
Bausch Health revenue by segment 2021-2024 - Statista
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Bausch Health Upsizes Private Offering to $4.4 Billion - TipRanks
Bausch Health upsizes senior notes offering to $4.4 billion By Investing.com - Investing.com South Africa
Bausch Health upsizes senior notes offering to $4.4 billion - Investing.com India
Bausch Health Prices Upsized Private Offering of Senior Secured Notes - MarketScreener
Bausch Health Announces Pricing Of Upsized Private Offering Of Senior Secured Notes - Marketscreener.com
Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes - ACCESS Newswire
Shareholders in Bausch Health Companies (NYSE:BHC) are in the red if they invested three years ago - Yahoo Finance
Bausch Health announces debt refinancing plans By Investing.com - Investing.com South Africa
Bausch Health announces debt refinancing plans - Investing.com
Bausch Health Announces Conditional Redemption of Senior Notes - TipRanks
Bausch Health Brief: Announcing Conditional Redemption of Senior Notes -March 21, 2025 at 04:24 pm EDT - MarketScreener
Bausch Health's Massive $7.4B Debt Overhaul Extends Maturity to 2032 - StockTitan
After losing 25% in the past year, Bausch Health Companies Inc. (NYSE:BHC) institutional owners must be relieved by the recent gain - simplywall.st
Bausch Health finance plan gets thumbs up at Raymond James - Cantech Letter
BHC Stock Price, News and Analysis - Cantech Letter
Optical Coherence Tomography Devices Market Future Business - openPR
Raymond James maintains Bausch Health stock Market Perform By Investing.com - Investing.com South Africa
Raymond James maintains Bausch Health stock Market Perform - Investing.com
Bausch Health seeks $3.8 billion in new credit facilities - Investing.com Australia
Bausch + Lomb credit rating upgraded to ’B’ at S&P, parent company outlook developing - Investing.com
Bausch Health seeks $3.8 billion in new credit facilities By Investing.com - Investing.com South Africa
Bausch Health Launches $4 Billion Note Offering to Restructure Debt - TipRanks
Bausch Health Launches Syndication Of New Senior Secured Credit Facilities Totaling At Least $3.8 Bln - MarketScreener
Bausch Health Launches $3.8 Billion Credit Facilities -March 19, 2025 at 12:15 pm EDT - Marketscreener.com
Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities - ACCESS Newswire
Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes - ACCESS Newswire
Intraocular Lens Market Research Methodologies Offers High - openPR
Bausch Health announces next steps in financining initiative - Yahoo Finance
Bausch Health Companies Announces Next Steps In Financing Initiative With J.P. Morgan - Marketscreener.com
Bausch Health seeks financing with J.P. Morgan aid By Investing.com - Investing.com South Africa
Bausch Health seeks financing with J.P. Morgan aid - Investing.com India
Bausch Health Brief: Says Has engaged J.P. Morgan in connection with Its previously announced financing objectives - Marketscreener.com
Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan - Voice Of Alexandria
Bausch Health Taps JP Morgan to Lead Major Financial Restructuring Initiative - StockTitan
What is Zacks Research’s Forecast for BHC Q2 Earnings? - Defense World
Acne Market on Track for Major Expansion by 2032, According to DelveInsight | Clinuvel Pharma, Novan, Dermata Therapeutics, ioPharmX, Bausch Health Americas, Inc., Kintor Pharma, Sol-Gel Technologies - Barchart
Microkeratome Market Detailed In New Research Report 2025 | - openPR
Overt Hepatic Encephalopathy Treatment Market: Key - openPR
Bausch Health Companies Inc. (NYSE:BHC) Receives $7.42 Consensus PT from Analysts - Defense World
Finanzdaten der Bausch Health Companies Inc-Aktie (BHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.06%
0.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):